C&C Research Labs, a subsidiary of JW Pharmaceutical, and XtalPi, a U.S.-based artificial intelligence drug development company, said they will cooperate in developing small molecule therapeutics, focusing on targeting the STAT6 protein, a key player in inflammatory immune responses.XtalPi, founded
SAN DIEGO, Calif. – By Lee Han-soo/Korea Biomedical Review correspondent -- A new study on the treatment of Extranodal NK/T-cell lymphoma (ENKTL) using a combination of isatuximab and cemiplimab has shown promising results, as reported by Professor Kim Seok-jin at Samsung Medical Center during the A
SAN DIEGO, Calif. – By Lee Han-soo/Korea Biomedical Review correspondent -- A recent study presented at the American Society of Hematology (ASH) 2023 conference in San Diego has highlighted the potential benefits of combining AbbVie's epcoritamab and lenalidomide for patients with relapsed/refractor
SAN DIEGO, Calif. – By Lee Han-soo/Korea Biomedical Review correspondent -- Korean researchers have presented evidence that brings people a step closer to achieving the goal of treatment-free remission (TFR) in the treatment of chronic myeloid leukemia (CML). Capturing significant attention, the res
SAN DIEGO, Calif. – By Lee Han-soo/Korea Biomedical Review correspondent -- The 65th American Society of Hematology (ASH) opened the world's largest hematology conference in San Diego, Calif, the U.S., on Saturday.According to the organizers, the exhibition will be participated by 275 exhibitors and
Korea Drug Development Fund (KDDF) has selected four companies -- Medytox, TiumBio, AbClon, and MedPacto as part of its “2023 third National New Drug Development Project”.The project is an inter-ministerial research and development (R&D) project that supports the entire cycle of new drug development
EOFlow said that it has terminated the contract with Medtronic for the latter to acquire the company."Over the past few weeks, both sides have worked to find common ground, but due to fundamental differences in view regarding the recent situation of our company, we decided to terminate the contract
A research team at Severance Hospital has proposed a new primary treatment strategy for HER2-negative advanced gastric cancer.The oncology team of Yonsei Cancer Center, led by Professor Rha Sun-young, conducted a treatment combining Keytruda with conventional chemotherapy for patients with HER2-nega
Sanofi Korea said its high-dose influenza vaccine Efluelda, designed for seniors, received marketing authorization from the Ministry of Food and Drug Safety on Nov. 29.Efluelda is the first high-dose influenza vaccine approved in Korea for the elderly, preventing influenza caused by type A and B vir
Celltrion said it has signed a joint research agreement with Cyron Therapeutics, a Korean company specializing in antibody discovery and development, for the development of cancer drugs based on multi-antibodies.Under the accord, Celltrion will provide target antibody clones to Cyron, and Cyron will
Wells Bio, a subsidiary of Access Bio, said it aims to contribute to the global fight against the Mycoplasma pneumonia outbreak in Asia and Europe by exporting its careGENE Pneumonia Detection Kit, a molecular diagnostic reagent for pneumonia.Mycoplasma pneumonia shares symptoms with epidemic influe
The Korean securities industry is revising upward the stock price targets for traditional pharmaceutical companies, pointing to licensing deals and export growth.As per the investment banking (IB) sector, domestic securities firms are upwardly adjusting target prices for major traditional pharmaceut
Kwangdong Pharmaceutical said it had signed a memorandum of understanding regarding the transfer of shares of BL Healthcare from BL Pharmtech, the largest shareholder.Under the accord, Kwangdong has agreed to acquire 58.74 percent of BL Healthcare from BL Pharmtech.The key provisions of the MOU incl
Seoul National University Bundang Hospital (SNUBH) has announced research findings that the use of five or more drugs and inappropriate medications among older adults in Korea is increasing annually, leading to a significant rise in the risk of death or disability.The research team at SNUBH, led by
Singer and producer Park Jin-young, more famously known as JYP, has donated 1 billion won ($763,766) to five hospitals in Korea to support the treatment costs for underprivileged children.JYP, the former head of JYP Entertainment, decided to make a generous donation to help children and adolescents
Samsung Bioepis and Intocell have announced the signing of a joint research agreement for the development and validation of candidate materials in the field of antibody-drug conjugates (ADC).Founded in 2015, Intocell is a Korean company focused on the development of ADC linker-drug technologies. The
Celltrion said it confirmed the efficacy of CT-P42, a biosimilar referencing Eylea (ingredient: aflibercept), in a phase 3 study. The company presented the trial results during the FLORetina–ICOOR 2023 conference.Eylea is a blockbuster ophthalmic drug developed by Regeneron and treats wet age-relate
Bluemtec, a pharmaceutical e-commerce company, said it will start co-marketing two MSD’s vaccines -- one for hepatitis A the other for Measles, Mumps, and Rubella (MMR) –- in Korea from January 1, 2024.This marks the first joint vaccine sale between a local distributor and a global pharmaceutical co
SLS Bio, a Kosdaq-listed developer of pharmaceuticals and diagnostic reagents, said it has entered into a contract with a global pharmaceutical company for the quality inspection and management testing of mRNA vaccines, without providing the name of the mutinational pharma. According to SLS Bio, the
CHICAGO, Ill. -- By Lee Han-soo/Korea Biomedical correspondent – With the increase in diagnostic data and ongoing workforce shortages contributing to high levels of burnout among radiologists, Philips is focusing on innovating solutions that aim to streamline radiological processes.Led by Chief Inno